LENFOMALI HASTALARDA KEMOTERAPİNİN YAŞAM KALİTESİNE ETKİSİ

Esra Saatçi; Yüksel Koçak; Nafiz Bozdemir; Ersin Akpınar; Zeynep Kalaylıoğlu-wheeler

-

Year 2007, Volume: 20 Issue: 2, 98 - 103, 25.06.2015

Esra Saatçi , Yüksel Koçak Nafiz Bozdemir Ersin Akpınar Zeynep Kalaylıoğlu-wheeler

Abstract

Keywords

References

Guyatt G, Veldhuyzen Van Zanten S, Feeny D, Patrick
D. Measuring quality of life in clinical trials: a taxonomy
and review. Can Med Assoc J 1989; 140: 1441-1448.
Lauper P, Versteegen U. The importance of quality of
life in policy decisions: new end points in medical
outcome assessment. Pharm Med 1992; 5: 43-50.
Schumacher A, Kessler T, Riedel A, Buchner T, van de
Loo J. Quality of life and coping with illness in patients
with acute myeloid leukemia. Psychother Psychosom
Med Psychol 1996; 46: 385-390.
Jerkeman M, Kaasa S, Hjermstad M, Kvaloy S,
Cavallin-Stahl E. Health-related quality of life and its
potential prognostic implications in patients with
aggressive lymphoma: a Nordic Lymphoma Group Trial.
Medical Oncology 2001; 18: 85-94.
Persson L, Larsson G, Ohlsson O, Hallberg IR. Acute
leukemia or highly malignant lymphoma patients’
quality of life over two years: a pilot study. Eur J of
Cancer Care 2001; 10: 36-47.
Cella DF, Tulsky S. Measuring quality of life today:
methodological aspects. Oncology 1990; 4: 29-38.
The WHOQOL Group. The World Health Organization
quality of life assessment (WHOQOL): position paper
from the World Health Organization. Soc Sci Med 1995;
: 1403-1409.
Gotay CC, Korn EL, McCabe MS, Moore TD, Cheson
BD. Quality-of-life assessment in cancer treatment
protocols: research issues in protocol development. J
Natl Cancer Inst 1992; 84: 575-579.
Cella DF. Quality of life: the concept. J Palliat Care
; 8: 8-13.
Kaasa S, Loge JH. Quality of life in palliative care:
principles and practice. Palliat Med 2003; 17: 11-20.
Wierzbicka M, Kusnierkiewicz M, Wojtowicz JG,
Maune S, Szyfter W. The quality of life in head and neck
cancer patients: description of randomized examination
formula based on standardized questionnaires EORTC
QLQ C-30, EORTC QTQ-H-N35 and Kiel
Questionnaire. Otolaryngol Pol 2001; 55: 287-292 [in
Polish].
Kaasa S, Bjordal K, Aaronson N, et al. The EORTC
core quality of life questionnaire (QLQ-C30): validity
and reliability when analyzed with patients treated with
palliative radiotherapy. Eur J Cancer 1995; 31A: 2260-
-
Kobayashi K, Takeda F, Teramukai S, et al. A crossvalidation
of the European Organization for Research
and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30)
for Japanese with lung cancer. Eur J Cancer 1998; 34:
–815.
Osoba D, Aaronson N, Zee B, Sprangers M, te Velde A.
Modification of the EORTC QLQ-C30 (version 2.0)
based on content validity and reliability testing in large
samples of patients with cancer. The Study Group on
Quality of Life of the EORTC and the Symptom Control
and Quality of Life Committees of the NCI of Canada
Clinical Trials Group. Qual Life Res 1997; 6: 103-108.
Aaronson NK, Ahmedzai S, Bergman B, et al. The
European Organization for Research and Treatment of
Cancer QLQ-C30: a quality-of-life instrument for use in
international clinical trials in oncology. J Natl Cancer
Inst 1993; 85: 365-376.
Bjordal K, Ahlner-Elmqvist M, Tollesson E, et al.
Development of a European Organization for Research
and Treatment of Cancer (EORTC) questionnaire
module to be used in quality of life assessments in head
and neck cancer patients. EORTC Quality of Life Study
Group. Acta Oncol 1994; 33: 879-885.
Bjordal K, de Graeff A, Fayers PM, et al. A 12 country
field study of the EORTC QLQ-C30 (version 3.0) and
the head and neck cancer specific module (EORTC
QLQ-H&N35) in head and neck patients. EORTC
Quality of Life Group. Eur J Cancer 2000; 36: 1796-
-
Blazeby JM, Alderson D, Winstone K, et al.
Development of an EORTC questionnaire module to be
used in quality of life assessment for patients with
oesophageal cancer. The EORTC Quality of Life Study
Group. Eur J Cancer 1996; 32A: 1912-1917.
Sprangers MA, Cull A, Groenvold M, Bjordal K,
Blazeby J, Aaronson NK. The European Organization
for Research and Treatment of Cancer approach to
developing questionnaire modules: an update and
overview. EORTC Quality of Life Study Group. Qual
Life Res 1998; 7: 291-300.
Schumacher A, Kessler T, Buchner T, Wewers D, van
de Loo J. Quality of life in adult patients with acute
myeloid leukemia receiving intensive and prolonged
chemotherapy-a longitudinal study. Leukemia 1998; 12:
-592.
Ruffer JU, Flechtner H, Tralls P, et al. Fatigue in longterm
survivors of Hodgkin‘s lymphoma; a report from
the German Hodgkin Lymphoma Study Group (GHSG).
Eur J Cancer 2003; 39: 2179-2186.
Vogelzang NJ, Breitbart W, Cella D, et al. Patient,
caregiver, and oncologist perceptions of cancer-related
fatigue: results of a tripart assessment survey. The
Fatigue Coalition. Semin Hematol 1997; 34: 4-12.
Curt GA. The impact of fatigue on patients with cancer:
overview of FATIGUE 1 and 2. Oncologist 2000; 5
(Suppl 2): 9-12.

LENFOMALI HASTALARDA KEMOTERAPİNİN YAŞAM KALİTESİNE ETKİSİ

Year 2007, Volume: 20 Issue: 2, 98 - 103, 25.06.2015

Esra Saatçi , Yüksel Koçak Nafiz Bozdemir Ersin Akpınar Zeynep Kalaylıoğlu-wheeler

Abstract

Amaç: Kemoterapideki gelişmeler lenfomalı hastaların yaşam sürelerini önemli derecede uzatmıştır ve önemli sayıda hasta tedavi edilebilmektedir. Kemoterapi alan hastaların yaşam kalitelerinin değerlendirilmesi giderek daha fazla ilgi çeken bir konu olmuştur. Çalışmamızın amacı, lenfomalı hastalarda kemoterapinin yaşam kalitesine etkilerini değerlendirmektir. Gereç ve Yöntem: Haziran 2000-Ocak 2001 tarihleri arasında Çukurova Üniversitesi Tıp Fakültesi Onkoloji Bilim Dalı’nda Evre I lenfoma tanısı alan 49 hastaya kemoterapi öncesinde ve 2. kür sonrasında yaşam kalitesi anketi (EORTC QLQ C-30) uygulandı. Bulgular: Fiziksel aktivitelerin bazılarında, duygusal fonksiyonlar, ağrı ve halsizlik, dispne, iştahsızlık, uyku ve global yaşam kalitesinde tedavi sırasında anlamlı iyileşme saptandı. Kemoterapi, yaş, cinsiyet ve lenfoma tipi göz önüne alındığında, global yaşam kalitesini etkileyen en önemli faktör hastanın eğitim durumuydu. Sonuç: Çalışmamızın sonuçları, kemoterapi öncesindeki yaşam kalitesine kıyasla tedavi sonrası yaşam kalitesinde iyileşme olması nedeniyle, kemoterapi alma konusunda isteksiz olan hastalara yardımcı olmada kullanılabilir.

Anahtar Kelimeler: Lenfoma, Yaşam kalitesi, EORTC QLQ C-30, Adana

Keywords

References

Guyatt G, Veldhuyzen Van Zanten S, Feeny D, Patrick
D. Measuring quality of life in clinical trials: a taxonomy
and review. Can Med Assoc J 1989; 140: 1441-1448.
Lauper P, Versteegen U. The importance of quality of
life in policy decisions: new end points in medical
outcome assessment. Pharm Med 1992; 5: 43-50.
Schumacher A, Kessler T, Riedel A, Buchner T, van de
Loo J. Quality of life and coping with illness in patients
with acute myeloid leukemia. Psychother Psychosom
Med Psychol 1996; 46: 385-390.
Jerkeman M, Kaasa S, Hjermstad M, Kvaloy S,
Cavallin-Stahl E. Health-related quality of life and its
potential prognostic implications in patients with
aggressive lymphoma: a Nordic Lymphoma Group Trial.
Medical Oncology 2001; 18: 85-94.
Persson L, Larsson G, Ohlsson O, Hallberg IR. Acute
leukemia or highly malignant lymphoma patients’
quality of life over two years: a pilot study. Eur J of
Cancer Care 2001; 10: 36-47.
Cella DF, Tulsky S. Measuring quality of life today:
methodological aspects. Oncology 1990; 4: 29-38.
The WHOQOL Group. The World Health Organization
quality of life assessment (WHOQOL): position paper
from the World Health Organization. Soc Sci Med 1995;
: 1403-1409.
Gotay CC, Korn EL, McCabe MS, Moore TD, Cheson
BD. Quality-of-life assessment in cancer treatment
protocols: research issues in protocol development. J
Natl Cancer Inst 1992; 84: 575-579.
Cella DF. Quality of life: the concept. J Palliat Care
; 8: 8-13.
Kaasa S, Loge JH. Quality of life in palliative care:
principles and practice. Palliat Med 2003; 17: 11-20.
Wierzbicka M, Kusnierkiewicz M, Wojtowicz JG,
Maune S, Szyfter W. The quality of life in head and neck
cancer patients: description of randomized examination
formula based on standardized questionnaires EORTC
QLQ C-30, EORTC QTQ-H-N35 and Kiel
Questionnaire. Otolaryngol Pol 2001; 55: 287-292 [in
Polish].
Kaasa S, Bjordal K, Aaronson N, et al. The EORTC
core quality of life questionnaire (QLQ-C30): validity
and reliability when analyzed with patients treated with
palliative radiotherapy. Eur J Cancer 1995; 31A: 2260-
-
Kobayashi K, Takeda F, Teramukai S, et al. A crossvalidation
of the European Organization for Research
and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30)
for Japanese with lung cancer. Eur J Cancer 1998; 34:
–815.
Osoba D, Aaronson N, Zee B, Sprangers M, te Velde A.
Modification of the EORTC QLQ-C30 (version 2.0)
based on content validity and reliability testing in large
samples of patients with cancer. The Study Group on
Quality of Life of the EORTC and the Symptom Control
and Quality of Life Committees of the NCI of Canada
Clinical Trials Group. Qual Life Res 1997; 6: 103-108.
Aaronson NK, Ahmedzai S, Bergman B, et al. The
European Organization for Research and Treatment of
Cancer QLQ-C30: a quality-of-life instrument for use in
international clinical trials in oncology. J Natl Cancer
Inst 1993; 85: 365-376.
Bjordal K, Ahlner-Elmqvist M, Tollesson E, et al.
Development of a European Organization for Research
and Treatment of Cancer (EORTC) questionnaire
module to be used in quality of life assessments in head
and neck cancer patients. EORTC Quality of Life Study
Group. Acta Oncol 1994; 33: 879-885.
Bjordal K, de Graeff A, Fayers PM, et al. A 12 country
field study of the EORTC QLQ-C30 (version 3.0) and
the head and neck cancer specific module (EORTC
QLQ-H&N35) in head and neck patients. EORTC
Quality of Life Group. Eur J Cancer 2000; 36: 1796-
-
Blazeby JM, Alderson D, Winstone K, et al.
Development of an EORTC questionnaire module to be
used in quality of life assessment for patients with
oesophageal cancer. The EORTC Quality of Life Study
Group. Eur J Cancer 1996; 32A: 1912-1917.
Sprangers MA, Cull A, Groenvold M, Bjordal K,
Blazeby J, Aaronson NK. The European Organization
for Research and Treatment of Cancer approach to
developing questionnaire modules: an update and
overview. EORTC Quality of Life Study Group. Qual
Life Res 1998; 7: 291-300.
Schumacher A, Kessler T, Buchner T, Wewers D, van
de Loo J. Quality of life in adult patients with acute
myeloid leukemia receiving intensive and prolonged
chemotherapy-a longitudinal study. Leukemia 1998; 12:
-592.
Ruffer JU, Flechtner H, Tralls P, et al. Fatigue in longterm
survivors of Hodgkin‘s lymphoma; a report from
the German Hodgkin Lymphoma Study Group (GHSG).
Eur J Cancer 2003; 39: 2179-2186.
Vogelzang NJ, Breitbart W, Cella D, et al. Patient,
caregiver, and oncologist perceptions of cancer-related
fatigue: results of a tripart assessment survey. The
Fatigue Coalition. Semin Hematol 1997; 34: 4-12.
Curt GA. The impact of fatigue on patients with cancer:
overview of FATIGUE 1 and 2. Oncologist 2000; 5
(Suppl 2): 9-12.

There are 101 citations in total.

Details

Primary Language	Turkish
Journal Section	Articles
Authors	Esra Saatçi Yüksel Koçak This is me Nafiz Bozdemir This is me Ersin Akpınar This is me Zeynep Kalaylıoğlu-wheeler This is me
Publication Date	June 25, 2015
Published in Issue	Year 2007 Volume: 20 Issue: 2

Cite

APA	Saatçi, E., Koçak, Y., Bozdemir, N., Akpınar, E., et al. (2015). LENFOMALI HASTALARDA KEMOTERAPİNİN YAŞAM KALİTESİNE ETKİSİ. Marmara Medical Journal, 20(2), 98-103.
AMA	Saatçi E, Koçak Y, Bozdemir N, Akpınar E, Kalaylıoğlu-wheeler Z. LENFOMALI HASTALARDA KEMOTERAPİNİN YAŞAM KALİTESİNE ETKİSİ. Marmara Med J. August 2015;20(2):98-103.
Chicago	Saatçi, Esra, Yüksel Koçak, Nafiz Bozdemir, Ersin Akpınar, and Zeynep Kalaylıoğlu-wheeler. “LENFOMALI HASTALARDA KEMOTERAPİNİN YAŞAM KALİTESİNE ETKİSİ”. Marmara Medical Journal 20, no. 2 (August 2015): 98-103.
EndNote	Saatçi E, Koçak Y, Bozdemir N, Akpınar E, Kalaylıoğlu-wheeler Z (August 1, 2015) LENFOMALI HASTALARDA KEMOTERAPİNİN YAŞAM KALİTESİNE ETKİSİ. Marmara Medical Journal 20 2 98–103.
IEEE	E. Saatçi, Y. Koçak, N. Bozdemir, E. Akpınar, and Z. Kalaylıoğlu-wheeler, “LENFOMALI HASTALARDA KEMOTERAPİNİN YAŞAM KALİTESİNE ETKİSİ”, Marmara Med J, vol. 20, no. 2, pp. 98–103, 2015.
ISNAD	Saatçi, Esra et al. “LENFOMALI HASTALARDA KEMOTERAPİNİN YAŞAM KALİTESİNE ETKİSİ”. Marmara Medical Journal 20/2 (August 2015), 98-103.
JAMA	Saatçi E, Koçak Y, Bozdemir N, Akpınar E, Kalaylıoğlu-wheeler Z. LENFOMALI HASTALARDA KEMOTERAPİNİN YAŞAM KALİTESİNE ETKİSİ. Marmara Med J. 2015;20:98–103.
MLA	Saatçi, Esra et al. “LENFOMALI HASTALARDA KEMOTERAPİNİN YAŞAM KALİTESİNE ETKİSİ”. Marmara Medical Journal, vol. 20, no. 2, 2015, pp. 98-103.
Vancouver	Saatçi E, Koçak Y, Bozdemir N, Akpınar E, Kalaylıoğlu-wheeler Z. LENFOMALI HASTALARDA KEMOTERAPİNİN YAŞAM KALİTESİNE ETKİSİ. Marmara Med J. 2015;20(2):98-103.